latest news
latest news
Find out what’s new at Alternate Health.
Canadian CBD Company Closes $20 Million U.S. Pharma Acquisition
June 20, 2019
TORONTO – June 20, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company has closed an amended acquisition agreement (the “Agreement”) to acquire 100% of Blaine Labs Inc. (“Blaine Labs”).
ALTERNATE HEALTH PROVIDES UPDATE ON FINANCING AGREEMENT
June 17, 2019
TORONTO – June 17, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company would like to provide an update on a financing facility agreement previously announced last Friday.
ALTERNATE HEALTH SECURES $5 MILLION FINANCING FACILITY FROM ALPHA BLUE OCEAN
June 14, 2019
TORONTO – June 14, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that it has entered into an agreement to obtain funds to finance Alternate Health’s expansion of its CBD product line and hemp extraction facility.
ALTERNATE HEALTH EXPANDS ENTERPRISE SALES OF CBD EDUCATION PLATFORM
May 29, 2019
TORONTO – May 29, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company’s subsidiary, Alternate Medical Media (“AMM”), has sold over 30 group education packages of its CBD Certification programs since launching institutional sales on March 30, 2019.
ALTERNATE HEALTH ANNOUNCES STRATEGIC CBD POSITIONING
May 16, 2019
TORONTO – May 16, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company is restructuring its assets towards the potential $22 billion American CBD industry, and is focusing exclusively on hemp-derived cannabinoid extraction, and manufacturing and distributing proprietary medical grade products.
Find out what’s new at Alternate Health.
Canadian CBD Company Closes $20 Million U.S. Pharma Acquisition
June 20, 2019
TORONTO – June 20, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company has closed an amended acquisition agreement (the “Agreement”) to acquire 100% of Blaine Labs Inc. (“Blaine Labs”).
ALTERNATE HEALTH PROVIDES UPDATE ON FINANCING AGREEMENT
June 17, 2019
TORONTO – June 17, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that the Company would like to provide an update on a financing facility agreement previously announced last Friday.
ALTERNATE HEALTH SECURES $5 MILLION FINANCING FACILITY FROM ALPHA BLUE OCEAN
June 14, 2019
TORONTO – June 14, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in hemp-derived CBD extraction, product development and distribution, announced today that it has entered into an agreement to obtain funds to finance Alternate Health’s expansion of its CBD product line and hemp extraction facility.
ALTERNATE HEALTH EXPANDS ENTERPRISE SALES OF CBD EDUCATION PLATFORM
May 29, 2019
TORONTO – May 29, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company’s subsidiary, Alternate Medical Media (“AMM”), has sold over 30 group education packages of its CBD Certification programs since launching institutional sales on March 30, 2019.
ALTERNATE HEALTH ANNOUNCES STRATEGIC CBD POSITIONING
May 16, 2019
TORONTO – May 16, 2019 – Alternate Health Corp., (“Alternate Health” or the “Company”) (CSE:AHG) (OTCQB:AHGIF), an international leader in CBD extraction, product development and distribution, announced today that the Company is restructuring its assets towards the potential $22 billion American CBD industry, and is focusing exclusively on hemp-derived cannabinoid extraction, and manufacturing and distributing proprietary medical grade products.